# | Title | Journal | Year | Citations |
---|
1 | Clinical review: intensive care unit acquired weakness | Critical Care | 2015 | 452 |
2 | Review of influenza-associated pulmonary aspergillosis in ICU patients and proposal for a case definition: an expert opinion | Intensive Care Medicine | 2020 | 278 |
3 | Effect of tolerating macronutrient deficit on the development of intensive-care unit acquired weakness: a subanalysis of the EPaNIC trial | Lancet Respiratory Medicine,the | 2013 | 255 |
4 | Repetitive 18-fluorodeoxyglucose positron emission tomography in isolated polymyalgia rheumatica: a prospective study in 35 patients | Rheumatology | 2006 | 231 |
5 | Interobserver agreement of medical research council sum‐score and handgrip strength in the intensive care unit | Muscle and Nerve | 2012 | 226 |
6 | NocardiaInfection in Solid Organ Transplant Recipients: A Multicenter European Case-control Study | Clinical Infectious Diseases | 2016 | 179 |
7 | Mycophenolate mofetil versus cyclophosphamide for remission induction in ANCA-associated vasculitis: a randomised, non-inferiority trial | Annals of the Rheumatic Diseases | 2019 | 165 |
8 | Assessment of Limb Muscle Strength in Critically Ill Patients | Critical Care Medicine | 2014 | 137 |
9 | Invasive pulmonary aspergillosis complicating severe influenza: epidemiology, diagnosis and treatment | Current Opinion in Infectious Diseases | 2018 | 133 |
10 | Incidence and outcome of invasive candidiasis in intensive care units (ICUs) in Europe: results of the EUCANDICU project | Critical Care | 2019 | 123 |
11 | Five-year impact of ICU-acquired neuromuscular complications: a prospective, observational study | Intensive Care Medicine | 2020 | 112 |
12 | Taskforce report on the diagnosis and clinical management of COVID-19 associated pulmonary aspergillosis | Intensive Care Medicine | 2021 | 106 |
13 | Autoantibodies in idiopathic inflammatory myopathies: Clinical associations and laboratory evaluation by mono- and multispecific immunoassays | Autoimmunity Reviews | 2019 | 100 |
14 | Bacteriophage Application for Difficult-to-treat Musculoskeletal Infections: Development of a Standardized Multidisciplinary Treatment Protocol | Viruses | 2019 | 98 |
15 | Feasibility of neuromuscular electrical stimulation in critically ill patients | Journal of Critical Care | 2014 | 97 |
16 | Intensive care unit acquired muscle weakness in COVID-19 patients | Intensive Care Medicine | 2020 | 93 |
17 | Outcome and Treatment of Nocardiosis After Solid Organ Transplantation: New Insights From a European Study | Clinical Infectious Diseases | 2017 | 91 |
18 | Reliability of the ica, aap and atlE genes in the discrimination between invasive, colonizing and contaminant Staphylococcus epidermidis isolates in the diagnosis of catheter—related infections | Clinical Microbiology and Infection | 2003 | 90 |
19 | Lactate Improves Prediction of Short‐Term Mortality in Critically Ill Patients With Cirrhosis: A Multinational Study | Hepatology | 2019 | 83 |
20 | Methodologies for in vitro and in vivo evaluation of efficacy of antifungal and antibiofilm agents and surface coatings against fungal biofilms | Microbial Cell | 2018 | 81 |
21 | Myeloablative Conditioning Predisposes Patients forToxoplasma gondiiReactivation after Allogeneic Stem Cell Transplantation | Clinical Infectious Diseases | 2010 | 77 |
22 | Pharmacist- versus physician-acquired medication history: a prospective study at the emergency department | BMJ Quality and Safety | 2010 | 76 |
23 | Impact of early parenteral nutrition completing enteral nutrition in adult critically ill patients (EPaNIC trial): a study protocol and statistical analysis plan for a randomized controlled trial | Trials | 2011 | 76 |
24 | Extremely elevated C-reactive protein | European Journal of Internal Medicine | 2006 | 66 |
25 | Interventions for preventing critical illness polyneuropathy and critical illness myopathy | | 2009 | 59 |
26 | Case Report: VEXAS Syndrome: From Mild Symptoms to Life-Threatening Macrophage Activation Syndrome | Frontiers in Immunology | 2021 | 59 |
27 | Solid phase assays versus automated indirect immunofluorescence for detection of antinuclear antibodies | Autoimmunity Reviews | 2018 | 57 |
28 | Use of 18F-fluorodeoxyglucose positron emission tomography in the diagnosis of polymyalgia rheumatica—A prospective study of 99 patients | Rheumatology | 2018 | 56 |
29 | De novo thrombotic microangiopathy after non-renal solid organ transplantation | Blood Reviews | 2014 | 51 |
30 | Convalescent plasma treatment of persistent severe acute respiratory syndrome coronavirus‐2 (SARS‐CoV‐2) infection in patients with lymphoma with impaired humoral immunity and lack of neutralising antibodies | British Journal of Haematology | 2021 | 51 |
31 | Beta- d -Glucan Detection as a Diagnostic Test for Invasive Aspergillosis in Immunocompromised Critically Ill Patients with Symptoms of Respiratory Infection: an Autopsy-Based Study | Journal of Clinical Microbiology | 2011 | 50 |
32 | Detection of antinuclear antibodies by automated indirect immunofluorescence analysis | Clinica Chimica Acta | 2013 | 50 |
33 | Aspergillus Test Profiles and Mortality in Critically Ill COVID-19 Patients | Journal of Clinical Microbiology | 2021 | 50 |
34 | Detection of myositis-specific antibodies | Annals of the Rheumatic Diseases | 2019 | 48 |
35 | Predictive value for weakness and 1-year mortality of screening electrophysiology tests in the ICU | Intensive Care Medicine | 2015 | 46 |
36 | Clubbing and hypertrophic osteoarthropathy: insights in diagnosis, pathophysiology, and clinical significance | Acta Clinica Belgica | 2016 | 38 |
37 | Early high antibody titre convalescent plasma for hospitalised COVID-19 patients: DAWn-plasma | European Respiratory Journal | 2022 | 38 |
38 | Assessment of quadriceps muscle mass with ultrasound in critically ill patients: intra- and inter-observer agreement and sensitivity | Intensive Care Medicine | 2015 | 36 |
39 | Predictors for unintentional medication reconciliation discrepancies in preadmission medication: a systematic review | European Journal of Clinical Pharmacology | 2017 | 36 |
40 | Autoantibodies against type I IFNs in patients with critical influenza pneumonia | Journal of Experimental Medicine | 2022 | 36 |
41 | Outbreak of trichinellosis related to eating imported wild boar meat, Belgium, 2014 | Eurosurveillance | 2016 | 34 |
42 | A simple tool to improve medication reconciliation at the emergency department | European Journal of Internal Medicine | 2011 | 33 |
43 | Factors Impacting Unbound Vancomycin Concentrations in Different Patient Populations | Antimicrobial Agents and Chemotherapy | 2015 | 33 |
44 | Subclinical giant cell arteritis in new onset polymyalgia rheumatica A systematic review and meta-analysis of individual patient data | Seminars in Arthritis and Rheumatism | 2022 | 32 |
45 | Inhaled liposomal amphotericin-B as a prophylactic treatment for COVID-19-associated pulmonary aspergillosis/aspergillus tracheobronchitis | Critical Care | 2021 | 31 |
46 | High prevalence of occupational exposure to solvents or silica in male systemic sclerosis patients: a Belgian cohort analysis | Clinical Rheumatology | 2018 | 30 |
47 | Sacituzumab govitecan and trastuzumab deruxtecan: two new antibody–drug conjugates in the breast cancer treatment landscape | ESMO Open | 2021 | 30 |
48 | Cytomegalovirus serostatus and outcome in nonimmunocompromised critically ill patients* | Critical Care Medicine | 2012 | 25 |
49 | The Association of Illness Perceptions with Physical and Mental Health in Systemic Sclerosis Patients: An Exploratory Study | Musculoskeletal Care | 2012 | 25 |
50 | Biological Therapy in Inflammatory Bowel Disease Patients Partly Restores Intestinal Innate Lymphoid Cell Subtype Equilibrium | Frontiers in Immunology | 2020 | 25 |